Abstract
Allen et al. reveal a molecular basis of antibody-mediated neutralization of Rift Valley fever virus, an important human and animal pathogen. They isolate and demonstrate the protective efficacy of a monoclonal antibody in a murine model of virus infection, providing a blueprint for rational therapeutic and vaccine design.
Original language | English |
---|---|
Pages (from-to) | 3750-3758.e4 |
Journal | Cell Reports |
Volume | 25 |
Issue number | 13 |
DOIs | |
Publication status | Published - 26 Dec 2018 |
Bibliographical note
Publisher Copyright:© 2018 The Author(s)
Keywords
- Rift Valley fever virus
- antibody
- antiviral
- bunyavirus
- immune response
- neutralization
- phlebovirus
- structure
- vaccine
- virus-host interactions